Therefore, suppressing TNF-α, TGF- β, CTGF and ET-1 expressions involves the degradation of collagen and mitigating of lung fibrosis, which partially describes the anti-fibrotic mechanism of PL in IPF. The gene discussed is TNF; the disease is pulmonary fibrosis.